Osterweis Capital Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Osterweis Capital Management's GH Position: Q2 2026 in Review
Osterweis Capital Management reduced its Guardant Health (GH) stake by 35% in Q2 2026, selling an estimated $5.61M and leaving 97,320 shares worth $14.6M. The position accounts for 0.69% of the portfolio, ranked #48.
Osterweis Capital Management first reported a position in GH in Q4 2019 and has held it in 10 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Osterweis Capital Management held 97,320 shares of Guardant Health worth $14.6M as of Q2 2026.
- Osterweis Capital Management sold 51,626 Guardant Health shares in Q2 2026, an estimated $5.61M.
- Guardant Health made up 0.69% of Osterweis Capital Management's portfolio in Q2 2026, its #48 holding.
- Osterweis Capital Management first reported a position in Guardant Health in Q4 2019 and has held it in 10 quarters since.
- 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Osterweis Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.